HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen, OTC Labeling Reg First Amendment Intrusions Cited By CTFA

This article was originally published in The Rose Sheet

Executive Summary

FDA's sunscreen and OTC labeling final regs will have difficulty passing constitutional muster in light of a recent court decision requiring agency-drafted disclaimers for a folic acid health claim, the Cosmetic, Toiletry and Fragrance Association maintains.

You may also be interested in...



FDA First Amendment Application Guidelines Urged By CTFA

FDA should develop guidelines laying out a First Amendment analysis that would be applied prior to any curtailment of marketing "speech" and followed "consistently throughout the agency," the Cosmetic, Toiletry and Fragrance Association asserts in Oct. 28 comments

FDA First Amendment Application Guidelines Urged By CTFA

FDA should develop guidelines laying out a First Amendment analysis that would be applied prior to any curtailment of marketing "speech" and followed "consistently throughout the agency," the Cosmetic, Toiletry and Fragrance Association asserts in Oct. 28 comments

Cosmetic Claims “Misleading” Standard Should Be Articulated By FDA – CTFA

FDA's development of a general policy statement on how it determines whether labeling claims for cosmetics and cosmetic-drugs are "inherently misleading" is urged by the Cosmetic, Toiletry and Fragrance Association in Sept. 13 comments to the agency

Related Content

UsernamePublicRestriction

Register

RS009141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel